Clinical trial
Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies
NCT03837119 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 4, 2018
- Completion date
- April 11, 2021
- Enrollment
- 540 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
heterozygous haemoglobinopathy